RBFOX2
Basic information
Region (hg38): 22:35738736-36028824
Previous symbols: [ "RBM9" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RBFOX2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 13 | 18 | ||||
missense | 25 | 30 | ||||
nonsense | 1 | |||||
start loss | 2 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 3 | 4 | |||
non coding | 6 | |||||
Total | 1 | 0 | 29 | 19 | 10 |
Variants in RBFOX2
This is a list of pathogenic ClinVar variants found in the RBFOX2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-35744211-G-C | Likely benign (Apr 19, 2023) | |||
22-35744254-A-G | Likely benign (Dec 20, 2018) | |||
22-35745928-C-T | Inborn genetic diseases | Uncertain significance (Aug 19, 2024) | ||
22-35745947-G-A | Inborn genetic diseases | Likely benign (Dec 20, 2023) | ||
22-35745952-G-A | Inborn genetic diseases | Uncertain significance (Aug 28, 2023) | ||
22-35745960-G-C | Uncertain significance (Jun 19, 2023) | |||
22-35745985-C-T | Inborn genetic diseases | Uncertain significance (Nov 24, 2024) | ||
22-35746474-C-A | Uncertain significance (Jan 04, 2024) | |||
22-35746475-G-T | Inborn genetic diseases | Uncertain significance (Jan 29, 2024) | ||
22-35746487-G-A | Inborn genetic diseases | Likely benign (Apr 29, 2024) | ||
22-35746491-G-A | Inborn genetic diseases | Uncertain significance (Jun 05, 2024) | ||
22-35746492-C-A | Uncertain significance (Jan 04, 2024) | |||
22-35746507-C-T | Inborn genetic diseases | Uncertain significance (Dec 07, 2024) | ||
22-35746517-G-A | Inborn genetic diseases | Likely benign (Sep 09, 2024) | ||
22-35756109-A-G | Uncertain significance (Nov 26, 2022) | |||
22-35756129-G-A | Likely benign (Mar 14, 2021) | |||
22-35759881-C-T | Likely benign (Jul 12, 2022) | |||
22-35759889-C-T | not specified | Uncertain significance (May 04, 2022) | ||
22-35759892-G-C | Inborn genetic diseases | Uncertain significance (Apr 19, 2023) | ||
22-35759898-C-T | Inborn genetic diseases | Uncertain significance (Dec 06, 2024) | ||
22-35759920-C-T | Likely benign (Jun 01, 2022) | |||
22-35759931-C-A | Inborn genetic diseases | Uncertain significance (Nov 07, 2022) | ||
22-35759994-C-G | Inborn genetic diseases | Uncertain significance (Dec 04, 2024) | ||
22-35760003-G-A | Inborn genetic diseases | Uncertain significance (Oct 04, 2024) | ||
22-35761247-G-A | Uncertain significance (Nov 18, 2016) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RBFOX2 | protein_coding | protein_coding | ENST00000438146 | 14 | 289691 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.999 | 0.000981 | 124485 | 0 | 1 | 124486 | 0.00000402 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.58 | 144 | 262 | 0.550 | 0.0000161 | 2844 |
Missense in Polyphen | 39 | 119.69 | 0.32584 | 1201 | ||
Synonymous | -0.278 | 109 | 105 | 1.03 | 0.00000720 | 935 |
Loss of Function | 4.40 | 1 | 24.5 | 0.0408 | 0.00000121 | 293 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000885 | 0.00000885 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: RNA-binding protein that regulates alternative splicing events by binding to 5'-UGCAUGU-3' elements. Prevents binding of U2AF2 to the 3'-splice site. Regulates alternative splicing of tissue-specific exons and of differentially spliced exons during erythropoiesis (By similarity). RNA-binding protein that seems to act as a coregulatory factor of ER-alpha. {ECO:0000250, ECO:0000269|PubMed:11875103}.;
- Pathway
- FGFR2 alternative splicing;Signaling by FGFR2;Signal Transduction;Signaling by FGFR;Signaling by Receptor Tyrosine Kinases
(Consensus)
Recessive Scores
- pRec
- 0.0922
Intolerance Scores
- loftool
- rvis_EVS
- -0.43
- rvis_percentile_EVS
- 25.15
Haploinsufficiency Scores
- pHI
- 0.467
- hipred
- Y
- hipred_score
- 0.725
- ghis
- 0.627
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rbfox2
- Phenotype
- growth/size/body region phenotype; cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- rbfox2
- Affected structure
- skeletal muscle
- Phenotype tag
- abnormal
- Phenotype quality
- decreased force
Gene ontology
- Biological process
- regulation of alternative mRNA splicing, via spliceosome;mRNA processing;nervous system development;RNA splicing;fibroblast growth factor receptor signaling pathway;regulation of definitive erythrocyte differentiation;RNA metabolic process;radial glia guided migration of Purkinje cell;intracellular estrogen receptor signaling pathway;regulation of cell population proliferation;negative regulation of transcription, DNA-templated;dendrite morphogenesis;neuromuscular process controlling balance
- Cellular component
- nucleus;nucleoplasm;cytoplasm;cytosol
- Molecular function
- transcription corepressor activity;RNA binding;mRNA binding;protein binding;transcription factor binding